SCHEMBL31269166

SCHEMBL31269166

Cc1ccnc(Cn2c(-c3ccc(OCC(=O)NCCO)cc3Cl)nc3c(OC4(C)CC4)ncnc32)c1

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.40
▸ PIK3CD O00329 1/20 0.33
▸ PDK2 Q15119 1/20 0.33
▸ RAB9A P51151 2/20 0.33
▸ ACACA Q13085 1/20 0.33
▸ LRRK2 Q5S007 1/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ RXFP1 Q9HBX9 1/20 0.32
▸ P2RX3 P56373 1/20 0.32
▸ MEN1 O00255 1/20 0.31
▸ KMT2A Q03164 1/20 0.31
▸ ADORA3 P0DMS8 1/20 0.31
▸ ADORA2B P29275 1/20 0.31
▸ ADORA1 P30542 1/20 0.31
▸ NPC1 O15118 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31
▸ GBA1 P04062 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31269453 0.96 ALDH1A1 (0.36) ALDH1A1PIK3CDRAB9ALRRK2KDM4E
SCHEMBL31269015 0.93 ALDH1A1 (0.32) ALDH1A1PIK3CDKDM4EMEN1KMT2A
SCHEMBL31268824 0.92 PIK3CD (0.34) ALDH1A1PIK3CDPDK2RAB9ANPC1
SCHEMBL31268842 0.91 PIK3CD (0.33) PIK3CDRAB9ANPC1
SCHEMBL31269460 0.91 PIK3CD (0.34) PIK3CDRAB9ANPC1
SCHEMBL31269027 0.90 PIK3CD (0.32) PIK3CDRAB9ANPC1
SCHEMBL31269392 0.90 PIK3CD (0.34) PIK3CDRAB9ANPC1
SCHEMBL31268837 0.90 KDM4E (0.33) ALDH1A1PIK3CDRAB9AKDM4ENPC1
SCHEMBL31268974 0.90 ALDH1A1 (0.35) ALDH1A1PIK3CDRAB9AKDM4ENPC1
SCHEMBL31268819 0.89 PIK3CD (0.36) PIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4689155-A1 USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS Astrazeneca AB (SE) 2026-02-11 — — EP disclosed
WO-2024201368-A1 USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS ASTRAZENECA AB (SE) 2024-10-03 — — WO disclosed
Send feedback